Cyclosporine With and Without Systemic Corticosteroids in Treatment of Alopecia Areata: A Systematic Review

Abstract Introduction Cyclosporine is commonly used in treatment for alopecia areata. It can be administered as a monotherapy or in combination with systemic corticosteroids, with various outcomes. Methods Efficacy of cyclosporine with and without systemic corticosteroids for alopecia areata was eva...

Full description

Bibliographic Details
Main Authors: Joanna Nowaczyk, Karolina Makowska, Adriana Rakowska, Mariusz Sikora, Lidia Rudnicka
Format: Article
Language:English
Published: Adis, Springer Healthcare 2020-04-01
Series:Dermatology and Therapy
Subjects:
Online Access:https://doi.org/10.1007/s13555-020-00370-2
id doaj-e2348b1857004da58720d9d4f5044728
record_format Article
spelling doaj-e2348b1857004da58720d9d4f50447282021-04-11T11:14:30ZengAdis, Springer HealthcareDermatology and Therapy2193-82102190-91722020-04-0110338739910.1007/s13555-020-00370-2Cyclosporine With and Without Systemic Corticosteroids in Treatment of Alopecia Areata: A Systematic ReviewJoanna Nowaczyk0Karolina Makowska1Adriana Rakowska2Mariusz Sikora3Lidia Rudnicka4Department of Dermatology, Medical University of WarsawDepartment of Dermatology, Medical University of WarsawDepartment of Dermatology, Medical University of WarsawDepartment of Dermatology, Medical University of WarsawDepartment of Dermatology, Medical University of WarsawAbstract Introduction Cyclosporine is commonly used in treatment for alopecia areata. It can be administered as a monotherapy or in combination with systemic corticosteroids, with various outcomes. Methods Efficacy of cyclosporine with and without systemic corticosteroids for alopecia areata was evaluated by a systematic review. Cochrane, EBSCOhost, Pubmed, Scopus and Web of Science databases were searched. Only studies published before January 2020 were included. Results A total of 2104 studies were initially examined, of which 14 were eligible for the systematic review. Among 340 reported cases, 213 had focal, multifocal or ophiasis form of alopecia areata, 60 were diagnosed with alopecia totalis and 67 with alopecia universalis. The mean response rate in the whole group of patients at the end of treatment was 65.00% (221/340; range 25–100%). Hair regrowth rate was higher in the group with cases of alopecia areata limited to scalp (124/165; mean 75.15%; range 40–100%) than in the cases with alopecia totalis (30/46; mean 65.22%; range 25–100%) or alopecia universalis (24/52; mean 46.15%; range 25–100%). The combined therapy with systemic corticosteroids was superior to the monotherapy (152/219; mean 69.41%; 0–80% vs. 69/121; mean 57.02%; range 6.67–100%) and had a lower recurrence rate (39/108; mean 36.11% vs. 34/46; mean 73.91%, respectively). The combined treatment with methylprednisolone was significantly more effective when compared to the cyclosporine monotherapy (124/183; mean 67.76%; range 0–80% vs. 69/121; mean 57.02%; range 6.67–100%). The mean time of treatment was 6.75 months (range 2–36). Limitations Limitations of our study were the retrospective character of included studies, differences in doses of prescribed drugs, and duration of the treatment and follow-up times. Conclusion Cyclosporine in combination with oral systemic corticosteroids is more effective than in monotherapy for severe alopecia areata.https://doi.org/10.1007/s13555-020-00370-2Alopecia areataAlopecia totalisAlopecia universalisCombined therapyCorticosteroidsCyclosporine
collection DOAJ
language English
format Article
sources DOAJ
author Joanna Nowaczyk
Karolina Makowska
Adriana Rakowska
Mariusz Sikora
Lidia Rudnicka
spellingShingle Joanna Nowaczyk
Karolina Makowska
Adriana Rakowska
Mariusz Sikora
Lidia Rudnicka
Cyclosporine With and Without Systemic Corticosteroids in Treatment of Alopecia Areata: A Systematic Review
Dermatology and Therapy
Alopecia areata
Alopecia totalis
Alopecia universalis
Combined therapy
Corticosteroids
Cyclosporine
author_facet Joanna Nowaczyk
Karolina Makowska
Adriana Rakowska
Mariusz Sikora
Lidia Rudnicka
author_sort Joanna Nowaczyk
title Cyclosporine With and Without Systemic Corticosteroids in Treatment of Alopecia Areata: A Systematic Review
title_short Cyclosporine With and Without Systemic Corticosteroids in Treatment of Alopecia Areata: A Systematic Review
title_full Cyclosporine With and Without Systemic Corticosteroids in Treatment of Alopecia Areata: A Systematic Review
title_fullStr Cyclosporine With and Without Systemic Corticosteroids in Treatment of Alopecia Areata: A Systematic Review
title_full_unstemmed Cyclosporine With and Without Systemic Corticosteroids in Treatment of Alopecia Areata: A Systematic Review
title_sort cyclosporine with and without systemic corticosteroids in treatment of alopecia areata: a systematic review
publisher Adis, Springer Healthcare
series Dermatology and Therapy
issn 2193-8210
2190-9172
publishDate 2020-04-01
description Abstract Introduction Cyclosporine is commonly used in treatment for alopecia areata. It can be administered as a monotherapy or in combination with systemic corticosteroids, with various outcomes. Methods Efficacy of cyclosporine with and without systemic corticosteroids for alopecia areata was evaluated by a systematic review. Cochrane, EBSCOhost, Pubmed, Scopus and Web of Science databases were searched. Only studies published before January 2020 were included. Results A total of 2104 studies were initially examined, of which 14 were eligible for the systematic review. Among 340 reported cases, 213 had focal, multifocal or ophiasis form of alopecia areata, 60 were diagnosed with alopecia totalis and 67 with alopecia universalis. The mean response rate in the whole group of patients at the end of treatment was 65.00% (221/340; range 25–100%). Hair regrowth rate was higher in the group with cases of alopecia areata limited to scalp (124/165; mean 75.15%; range 40–100%) than in the cases with alopecia totalis (30/46; mean 65.22%; range 25–100%) or alopecia universalis (24/52; mean 46.15%; range 25–100%). The combined therapy with systemic corticosteroids was superior to the monotherapy (152/219; mean 69.41%; 0–80% vs. 69/121; mean 57.02%; range 6.67–100%) and had a lower recurrence rate (39/108; mean 36.11% vs. 34/46; mean 73.91%, respectively). The combined treatment with methylprednisolone was significantly more effective when compared to the cyclosporine monotherapy (124/183; mean 67.76%; range 0–80% vs. 69/121; mean 57.02%; range 6.67–100%). The mean time of treatment was 6.75 months (range 2–36). Limitations Limitations of our study were the retrospective character of included studies, differences in doses of prescribed drugs, and duration of the treatment and follow-up times. Conclusion Cyclosporine in combination with oral systemic corticosteroids is more effective than in monotherapy for severe alopecia areata.
topic Alopecia areata
Alopecia totalis
Alopecia universalis
Combined therapy
Corticosteroids
Cyclosporine
url https://doi.org/10.1007/s13555-020-00370-2
work_keys_str_mv AT joannanowaczyk cyclosporinewithandwithoutsystemiccorticosteroidsintreatmentofalopeciaareataasystematicreview
AT karolinamakowska cyclosporinewithandwithoutsystemiccorticosteroidsintreatmentofalopeciaareataasystematicreview
AT adrianarakowska cyclosporinewithandwithoutsystemiccorticosteroidsintreatmentofalopeciaareataasystematicreview
AT mariuszsikora cyclosporinewithandwithoutsystemiccorticosteroidsintreatmentofalopeciaareataasystematicreview
AT lidiarudnicka cyclosporinewithandwithoutsystemiccorticosteroidsintreatmentofalopeciaareataasystematicreview
_version_ 1721531326885003264